Heart Failure with Preserved Ejection Fraction (HFpEF) Clinical Trials

Find Heart Failure with Preserved Ejection Fraction (HFpEF) Clinical Trials Near You

Exercise Capacity Improvement by Conduction System Pacing in heArt Failure patieNts Without Compelling CRT inDication

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomized controlled trial aims to investigate the impact of conduction system pacing in comparison to right ventricular apical pacing on exercise capacity, as measured by peak oxygen uptake (VO2peak), in heart failure patients with indication for pacing but no compelling indication for cardiac resynchronization therapy (CRT). The mechanisms of exercise intolerance in heart failure patients influenced by conduction system pacing will be assessed.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ Patients with heart failure as defined by European Society of Cardiology guidelines

• Signs and/or symptoms of heart failure

• AND LVEF \<50% OR LVEF ≥50% and objective evidence of cardiac structural and/or functional abnormalities consistent with the presence of LV diastolic dysfunction/raised filling pressures

• AND indication for cardiac pacing as defined by European Society of Cardiology guidelines

Locations
Other Locations
Belgium
Universitair Ziekenhuis Antwerpen
RECRUITING
Edegem
Contact Information
Primary
Andreas Gevaert
Andreas.gevaert@uza.be
038213538
Backup
Faro Verelst
Faro.verelst@uza.be
038213538
Time Frame
Start Date: 2023-12-12
Estimated Completion Date: 2027-12
Participants
Target number of participants: 75
Treatments
Experimental: Conduction system pacing
In the conduction system pacing group, the right ventricular lead will be placed in a septal position to achieve conduction system pacing, either His bundle pacing (HBP) or left bundle branch area (LBBA) pacing.
Active_comparator: Right ventricular apical pacing
Control group, in this group patients will receive a pacemaker with the ventricular lead in the right ventricle apex.
Sponsors
Leads: University Hospital, Antwerp

This content was sourced from clinicaltrials.gov